Education Tools

Below is a selection of tools that may be useful to community educators and healthcare providers.

Mental Health Worker Information Sheet

This simple fact sheet provides information for people working in Mental Health Services about discussing hepatitis C treatment and curing hepatitis C. It also dispels some of the myths related to hepatitis C.

View or download

Hepatitis C Education Presentations

These education slides have been designed to support hepatitis C education in CALD communities. They are written in the languages listed below and include the English translation. They are free for your use. You can also add slides to advertise your service or community. However you cannot not amend or edit Hepatitis Australia slides. If you have a query, or would like single PowerPoint slides please contact us via email to [email protected] and we will be happy to help where possible. Education slides will be reviewed regularly to remain current. CALD community fact sheets to support your educations sessions are available.

Page updated: 04 June 2019

Latest

Parliamentary Morning Tea: We can eliminate hepatitis C!

The Parliamentary Friends Group for Action of Blood Borne Viruses Co-Chairs, Tim Wilson, MP and Senator Louise Pratt invite you to a Parliamentary Morning Tea on Thursday 12 November.
Renewed calls for Needle & Syringe Programs in prisons ahead of International Drug Users Day

The Australian Injecting and Illicit Drug Users League (AIVL) and Hepatitis Australia are highlighting international calls for Needle and Syringe Programs (NSPs) in prisons, along with a greater focus on harm reduction initiatives, ahead of International Drug Users Day on 1 November.
Investment in hepatitis research needs to be accompanied by National Strategy implementation funding

6 October 2020 - Hepatitis Australia welcomes the Australian Government’s commitment to diverse hepatitis research, however we remain concerned that the 2019 Health Budget funding for hepatitis commitments is yet to hit the ground.
Investment in liver cancer medicines matched with prevention are changing Australian lives

6 October 2020 - Hepatitis Australia welcomes the Australian Government’s significant investment of $230 million to expand the listing of Tecentriq® and Avastin® (atezolizumab and bevacizumab) on the Pharmaceutical Benefits Scheme (PBS).

Hepatitis B Guide

Testing, treatment and staying healthy. This guide is to help you understand the process from being tested for hepatitis B (often called hep B) to living well with chronic (life-long) hep B.
Hepatitis C Guides

Testing and treating hepatitis C: Information for GPs and patients. Download these pdf resources specific to doctors and patients. Most patients with hep C can now be safely managed and cured in primary care.
Hepatitis Statistics

A summary of the latest surveillance data for hepatitis B and C in Australia.
National Strategies

Links to Australia's National Hepatitis Strategies 2018 2022